twitter
facebook

Home
Project
Scientific
News
Partners
Contributors
Contact

Scientific Area

Phases of the Project

Project Publications

Related Projects and Research

Related Policy and Legislation

Mid-Project Report

News

REDDSTAR will present at EU-MSC2 meeting in Leiden in September

August 3, 2017

REDDSTAR Final Project Leaflet

October 28, 2016

New REDDSTAR Publication in Neurobiology of Disease

October 20, 2016

Reddstar partners published in Neuropharmacology

July 7, 2016

REDDSTAR Plenary in Galway

April 27, 2016

Partners

NUI Galway
The Queen’s University of Belfast
Universidade do Porto
Charité – Universitätsmedizin Berlin
Ludwig-Maximilians-Universität München
Orbsen Therapeutics Limited
Owl Biomedical Inc
Pintail Ltd
Steno Diabetes Center A/S
Academisch Ziekenhuis Leiden – Leids Universitair Medisch Centrum (LUMC)

Twitter

RT @nephstrom: Where are the 4 @nephstrom #clinicaltrial sites? Treating #diabeticnephropathy with #MSCs #multipotent #mesenchymalstromalce… 07:57 AM 02, March 2019
RT @nephstrom: NEPHSTROM will deliver and validate a transformative mesenchymal stromal cell (MSC) treatment, ORBCEL-M. MSCs have demonstra… 07:56 AM 02, March 2019
Please follow our offshoot #MSC treatment for #diabetes and #kidney disease @nephstrom 08:25 AM 14, August 2018

Pages

Home
Project
Scientific
News
Partners
Contributors
Contact

Project Information

Copyright - FP7 REDDSTAR 2012

This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 305736. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.

Menu ✖

Home
Project
Scientific
News
Partners
Contributors
Contact